IBM Micromedex NeoFax for Android

11 things about IBM Micromedex NeoFax

1. Do you work at a facility that subscribes to IBM Micromedex NeoFax? Check with your Chief of Pediatrics, Director of Pediatrics, Director of the NICU, Directory of Pharmacy, Chief Medical Officer, Chief Nursing Officer, Medical Librarian, or anyone else at your facility responsible for clinical reference information.

2. IBM Micromedex NeoFax app is a reliable resource for on-the-go access to evidence-based drug information to efficiently and safely manage drug therapy for neonatal patients.

3. IBM Micromedex NeoFax drug information is intended for full-term babies up to 28 days of age (PNA) and preterm babies up to 44 weeks postmenstrual age (GA + PNA).

4. IBM Micromedex NeoFax is a trusted source for neonatal drug dosing, based on the strict editorial policies and practices that have guided IBM Micromedex NeoFax for more than 30 years.

5. The drug monographs cover information including: dose, administration, uses, contraindications/precautions, adverse effects, monitoring, pharmacology, special considerations/preparation, solution- and drug-drug compatibility/incompatibility information, and references.

6. If you work at a facility that subscribes to IBM Micromedex NeoFax, free access requires a password.

7. Evidence-based, fully referenced neonatal-specific drug information enables clinicians to make informed treatment decisions.

8. This mobile app also includes a comprehensive enteral formulas component providing nutritional information for approximately 60 different neonatal and infant formulas, and human milk fortifiers.

9. IBM Micromedex NeoFax app is free to subscribers of IBM Micromedex NeoFax online.

10. It allows clinicians to make accurate and more informed treatment decisions at the point of care, while minimizing errors in this vulnerable patient population.

11. An internet connection is not required, allowing you to make decisions with confidence at anytime, from anywhere.